Metronidazole Increases, Not Decreases, Serum Lithium Levels
No, metronidazole does not cause a decrease in serum lithium levels—it causes an INCREASE in serum lithium concentrations, which can lead to lithium toxicity. This is a critical drug interaction that requires close monitoring.
The Drug Interaction
The FDA-approved drug label for Flagyl (metronidazole) explicitly warns that "In patients stabilized on relatively high doses of lithium, short-term metronidazole therapy has been associated with elevation of serum lithium and, in a few cases, signs of lithium toxicity" 1. This is the authoritative source that should guide clinical practice.
Monitoring Requirements
Serum lithium and serum creatinine levels should be obtained several days after beginning metronidazole to detect any increase that may precede clinical symptoms of lithium intoxication 1. This proactive monitoring is essential because lithium has a narrow therapeutic window, and toxicity can develop rapidly.
Clinical Context from Guidelines
The KDOQI guidelines on CKD management reinforce the importance of lithium monitoring, noting that lithium is nephrotoxic and requires monitoring of GFR, electrolytes, and lithium levels every 6 months or more frequently if doses change or the patient becomes acutely unwell 2. The guideline specifically warns to avoid using concomitant NSAIDs and maintain hydration during intercurrent illness 2.
Research Evidence
Animal studies support this interaction mechanism. Research in rats demonstrated that metronidazole caused a delay in gastrointestinal absorption of lithium, leading to reduced serum lithium levels at 6 hours but increased levels at 24 hours 3. Importantly, this study found that antibiotics did not affect renal lithium clearance, suggesting the interaction occurs through altered absorption kinetics rather than renal mechanisms 3.
Clinical Management Algorithm
When prescribing metronidazole to a patient on lithium:
- Obtain baseline serum lithium and creatinine levels before starting metronidazole
- Recheck lithium levels 2-3 days after initiating metronidazole (before clinical toxicity manifests)
- Monitor for signs of lithium toxicity: tremor, confusion, ataxia, nausea, polyuria
- Consider dose adjustment of lithium if levels are elevated
- Recheck levels after completing metronidazole course as levels may fluctuate
Common Pitfall to Avoid
Do not assume that because a patient has been stable on lithium for years, they are safe from this interaction. The FDA label specifically mentions patients "stabilized on relatively high doses" are at risk 1. Even therapeutic lithium levels can become toxic with this interaction.
Alternative Consideration
If metronidazole can be avoided, consider clindamycin as an alternative for anaerobic coverage, particularly in patients with high lithium levels or those at risk for toxicity. However, if metronidazole is clinically necessary (e.g., for specific protozoal infections or C. difficile), proceed with intensive monitoring rather than withholding necessary treatment.